ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expressionXin Hu|OncoTargets and Therapy|2014Cited by 15
A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genomeChang Xu, Xia Xue, Xing Zhao et al.|BMC Nephrology|2021Cited by 3
Integrative analysis of metabolic subtypes in triple-negative breast cancer reveals new therapeutic strategiesYue Gong, Zhimin Shao, Y.-Z. Jiang et al.|Annals of Oncology|2019Cited by 2